The global alginate dressing market is anticipated to grow at a considerable CAGR of 4.9% during the forecast period. The rising incidence of acute & chronic wounds such as diabetic foot ulcers, venous leg ulcers, pressure ulcers, surgical & traumatic wounds, burns, and others is boosting the global alginate dressing market. As alginate dressings are widely used in the treatment of exuding wounds and due to its antibacterial activity, alginate dressing takes up wound exudates, through the creation of a gel surface that absorbs moisture and maintains a moist environment for the wound, which is preferred for these kinds of wounds for faster recovery and protection from infections.
Browse the full report description of “Alginate Dressing Market Size, Share & Trends Analysis Report by Type (Antimicrobial, and Non-antimicrobial), by Application (Chronic Wounds and Acute Wounds), and by End-Use(Hospitals, Home Healthcare, and Clinics) Forecast Period (2022-2028)” at https://www.omrglobal.com/industry-reports/alginate-dressing-market
According to National Institute for Health and Care Excellence (NICE) data for 2020, the incidence of leg ulcers is increasing, around 1.5% of the adult population have an ulcer and about 80% of all leg ulcers are venous leg ulcers in the UK, which require proper treatment such as applying medication or dressings to the ulcer. Treatment includes controlling the pressure in the leg veins by elevation of the limb, compression therapy, and the use of an appropriate dressing such as alginate dressing. Further according to, Agency for Healthcare Research and Quality (AHRQ) US data, each year more than 2.5 million people in the US develop pressure ulcers. These skin lesions bring pain, associated risk for serious infection, and increased health care utilization.
In addition, surgical site infections (SSI) are the second most frequently reported infections of all nosocomial infections among hospital patients. According to the Agency for Healthcare Research and Quality (AHRQ), SSIs occur in 2% to 4% of all patients undergoing inpatient surgical procedures. Although most infections are treatable with antibiotics, SSIs remain a significant cause of morbidity and mortality after surgery. They are the leading cause of readmissions to the hospital following surgery, and around 3% of patients who develops an SSI will die as a result. These factors are increasing the demand for alginate dressing across the globe as alginate dressings consist of soft non-woven fibers of a cellulose-like polysaccharide derived from the calcium salts of seaweed. They are biodegradable, hydrophilic, non-adherent, and highly absorbent and used by doctors for patients to heal their wounds quickly and safely.
Market Coverage
• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Type
o By Application
o By End-Use
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- including 3M, B. Braun Melsungen AG, BSN medical, Inc., Cardinal Health, Inc., Smith & Nephew plc, and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Alginate Dressing Market Report Segment
By Type
By Application
By End-Use
Global Alginate Dressing Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/alginate-dressing-market